Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ARHP Angle: We Need a Few Good Leaders!

Pamela Degotardi, PhD  |  August 1, 2009

Flying back from Cincinnati, where I’d been attending a meeting of the ARHP Committee on Nominations, it occurred to me that some members might be intrigued by the process of how ARHP officers and committee and subcommittee chairs are selected. While I do realize that some members aren’t interested in the structural organization of ARHP, I know some may ask, “Why was she selected and not me?”

Within Our Reach–Funded Research Finds Highly Specific Markers of RA

Staff  |  August 1, 2009

A study recently published in Arthritis & Rheumatism concluded that anti–peptidyl arginine deiminase type 4 (PAD-4) antibodies are highly specific markers of RA and appear to be useful markers of disease severity. The project studied an important and previously unrecognized immune response in RA—anti–PAD-4, which is one of the major proteins that creates other common autoantigens in RA.

Coding Corner Question

Staff  |  August 1, 2009

August’s Coding Challenge

Coding Corner Answer

Staff  |  August 1, 2009

August’s Coding Answer

2009 Annual Meeting Goes Beyond the Basics for Basic Researchers

Staff  |  August 1, 2009

Attendees at the 2009 ACR/ ARHP Annual Scientific Meeting will find multiple opportunities to increase their knowledge.

Doused in Denmark

David S. Pisetsky, MD, PhD  |  August 1, 2009

EULAR captured the complex picture of rheumatology’s future

Letters

Staff  |  August 1, 2009

Feedback From Our Readers

Productive Partnership

Sherine Gabriel, MD, and Leslie J. Crofford, MD  |  August 1, 2009

The ACR and the REF work closely to support the future of rheumatology

Immunizations in Immunocomprised Patients

Gretchen Henkel  |  August 1, 2009

Vaccines can help minimize certain diseases

REMS Required

Vanessa Caceres  |  August 1, 2009

How will this FDA drug safety program affect rheumatology offices?

  • « Previous Page
  • 1
  • …
  • 757
  • 758
  • 759
  • 760
  • 761
  • …
  • 815
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences